Categories

Trending News + Events

MiraVista Partnered with DVM360 to Sponsor a 1-hr RACE® Approved Course

MiraVista Partnered with DVM360 to Sponsor a 1-hr RACE® Approved Course

MiraVista partnered with DVM360 to sponsor a 1-hr RACE® approved course on antifungal therapy in small animals. Key Learning Objectives: Treatment of choice for common invasive fungal infections. Monitoring antifungal treatment to avoid adverse effects. Available options for salvage therapy. Click here to register for this complimentary, on-demand course.
ITRACONAZOLE: How to Adjust Dose Based on MVista® Bioassay Result

ITRACONAZOLE: How to Adjust Dose Based on MVista® Bioassay Result

At a Glance – Crucial Information 1. Itraconazole is an effective and commonly used antifungal drug 2. Adverse effects (AEs) are reported in 8-33% of dogs and cats treated 3. AEs are more common with higher itraconazole blood levels 4. Treatment failure is more likely with sub-therapeutic blood levels 5. Blood levels are highly...
Read More →
CUSTOMER & TECHNICAL SERVICE UPDATE

CUSTOMER & TECHNICAL SERVICE UPDATE

MiraVista has created a summary of recommendations from the current literature on diagnosis and treatment of blastomycosis. This brief serves as a reference for information regarding background, clinical findings, diagnosis, treatment and monitoring for blastomycosis. Contributors include Drs. Joe Wheat, Janelle Renschler, and Heather Largura.
MiraVista Sponsors Veterinary Continuing Education Seminar in Milwaukee

MiraVista Sponsors Veterinary Continuing Education Seminar in Milwaukee

MiraVista is sponsoring a veterinary continuing education seminar in Milwaukee, Wisconsin on September 27, 2018. The topic is Getting the Most from Your Lab Work. Attendees can earn 1.5 hours of CE credit through the Milwaukee Veterinary Medical Association (MVMA). Veterinary Continuing Education This seminar is part of a veterinary continuing education (CE) program hosted...
Read More →
Contact Us
CREDENTIALS: